Suppression of transcription factor NF-kappa B activity by Bcl-2 protein in NIH3T3 cells: implication of a novel NF-kappa B p50-Bcl-2 complex for theanti-apoptotic function of Bcl-2

Bcl-2 can suppress apoptosis by controlling genes that encode proteins requ ired for programmed cell death and by interference with peroxidative damage . Overexpression of Bcl-2 in NIH3T3 cells can prevent GSNO-induced (S-nitro soglutathione-induced) apoptosis. The experimental results indicated that a ctivation of NF-KB by GSNO is involved in inducing apoptosis. Surprisingly, we found that Bcl-2 delayed the release of IkB by formation of a Bcl-2-NF- kappa B complex (p50-p65-I kappa B) in the cytoplasm during cell apoptosis. Furthermore, a novel Bcl-2-p50 complex was found in the nucleus. These fea tures were only observed in Bcl-2-transfected cells but not in the parental NIH3T3 cells. Overexpression of Bcl-2 suppressed the levels of c-myc, a ta rget gene of NF-kappa B, and influenced the DNA-binding activity of NF-KB d uring GSNO-induced apoptosis. We suggest that the Bcl-2-p50 complex inhibit s NF-KB DNA-binding activity by competing with the p65-p50 heterodimer for the DNA-binding site in the nucleus. Finally, it has been demonstrated that the anti-apoptotic potential of Bcl-2 may be attributed to its complexing with p50 in the nucleus that leads to blockage of nuclear gene expression.